Virtus ETF Advisers’s Allogene Therapeutics ALLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-35,194
| Closed | -$75K | – | 279 |
|
|
2024
Q4 | $75K | Sell |
35,194
-1,091
| -3% | -$2.32K | 0.03% | 348 |
|
|
2024
Q3 | $102K | Buy |
36,285
+645
| +2% | +$1.81K | 0.05% | 374 |
|
|
2024
Q2 | $83K | Buy |
35,640
+3,673
| +11% | +$8.56K | 0.04% | 390 |
|
|
2024
Q1 | $143K | Sell |
31,967
-2,196
| -6% | -$9.82K | 0.08% | 334 |
|
|
2023
Q4 | $110K | Buy |
34,163
+14,328
| +72% | +$46K | 0.07% | 331 |
|
|
2023
Q3 | $62.9K | Sell |
19,835
-1,978
| -9% | -$6.27K | 0.04% | 400 |
|
|
2023
Q2 | $108K | Buy |
21,813
+8,742
| +67% | +$43.4K | 0.06% | 348 |
|
|
2023
Q1 | $64.6K | Sell |
13,071
-5,026
| -28% | -$24.8K | 0.04% | 414 |
|
|
2022
Q4 | $114K | Buy |
18,097
+6,635
| +58% | +$41.7K | 0.06% | 431 |
|
|
2022
Q3 | $124K | Buy |
11,462
+79
| +0.7% | +$855 | 0.05% | 388 |
|
|
2022
Q2 | $130K | Buy |
11,383
+535
| +5% | +$6.11K | 0.05% | 350 |
|
|
2022
Q1 | $99K | Sell |
10,848
-639
| -6% | -$5.83K | 0.04% | 304 |
|
|
2021
Q4 | $171K | Buy |
11,487
+3,108
| +37% | +$46.3K | 0.06% | 277 |
|
|
2021
Q3 | $215K | Sell |
8,379
-438
| -5% | -$11.2K | 0.09% | 250 |
|
|
2021
Q2 | $230K | Sell |
8,817
-1,904
| -18% | -$49.7K | 0.09% | 241 |
|
|
2021
Q1 | $378K | Buy |
10,721
+185
| +2% | +$6.52K | 0.16% | 192 |
|
|
2020
Q4 | $266K | Buy |
10,536
+2,925
| +38% | +$73.8K | 0.11% | 287 |
|
|
2020
Q3 | $287K | Sell |
7,611
-1,039
| -12% | -$39.2K | 0.15% | 233 |
|
|
2020
Q2 | $370K | Sell |
8,650
-4,629
| -35% | -$198K | 0.18% | 236 |
|
|
2020
Q1 | $258K | Sell |
13,279
-1,935
| -13% | -$37.6K | 0.11% | 245 |
|
|
2019
Q4 | $395K | Buy |
15,214
+5,662
| +59% | +$147K | 0.06% | 260 |
|
|
2019
Q3 | $260K | Sell |
9,552
-532
| -5% | -$14.5K | 0.05% | 213 |
|
|
2019
Q2 | $271K | Buy |
+10,084
| New | +$271K | 0.06% | 258 |
|